Results about: biomarkers


New combination therapy for breast tumours, with selection marker

Researchers demonstrate the presence of stable beta-amyloid dimers in the brains of patients with Alzheimer’s disease

A study headed by IRB Barcelona provides the first direct evidence of beta-amyloid dimers (two proteins joined together) in patients with Alzheimer’s disease and points to the potential of these molecules as biomarkers.

Beta-amyloid dimers may be the smallest pathological species that trigger Alzheimer’s disease.